Jefferies believes aggressive moves by incumbents and entry of new players in the QC space can result in higher discounting ...
Key stocks recommended by Jefferies for 2025 include Mankind Pharma, JB Chemicals, and Sun Pharmaceutical Industries.
The global brokerage firm revised the target lower, citing increasing competition as a threat to the online food aggregator’s ...
12h
After Zomato’s shares more than doubled in value in 2024, analysts at Jefferies predict that 2025 could be a breather year, with the stock likely shifting gears into a phase of price consolidation.
Jefferies downgraded Blue Star Ltd. to 'hold' from 'buy' after the stock rallied 140% in calendar year 2024. The stock is now ...
Jefferies analyst Brent Thill upgraded Procore (PCOR) to Buy from Hold with a price target of $100, up from $80. The firm expects a favorable ...
24/7 Wall St. on MSN5d
Jefferies Adds 3 Growth and Dividend Superstars to Top Picks List for 2025Jefferies has made some changes to its well-respected Franchise Picks list. Three of its picks for 2025 look like outstanding ...
After the 140 percent rally of Blue Star shares, there is limited upside potential for the stock, said Jefferies.
The yield on 10-year Bunds edged up and Jefferies said it had a buy level at 2.40%, so would prefer “a long position at [the] current level.” ...
Zacks.com on MSN2h
IB & Trading to Aid Jefferies' Q4 Earnings, High Costs to HurtJefferies Financial Group Inc. JEF is slated to report fourth-quarter and full-year fiscal 2024 (ended Nov. 30) results ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback